Sitna Ali Mwanzi: Molecular Profile of NSCLC in a predominantly Black African Population in Kenya
Sitna Ali Mwanzi, Head of Department Cancer Treatment Centre at Kenyatta National Hospital, shared a post on LinkedIn:
“Publication alert
Check out our new article on ‘Molecular Profile of Non-Small Cell Lung Cancer in a predominantly Black African Population in Kenya: A single institution review” published online on Translational Oncology
Key takeaways
Mean age in our cohort was 62 years
47% female
73% with stage IV disease at diagnosis
85% with adenocarcinoma
EGFR mutation was the most commonly requested test (full panel in only a small % of patients) – 35% of those tested had a mutation – rates similar to Asian population
Next steps
Increase access to testing – an access program for EGFR testing already present in Kenya from 2023, many labs exploring full panel testing (EGFR/ALK/ROS/PD L1 locally)
Increase access to targeted therapies
Larger study incorporating survival outcomes
Special thanks to the co-authors Shaheen Sayed, Asim Jamal Shaikh, Jonathan Wawire, Priscilla Njenga, swati das, Jasmit Shah (Sumaria)”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023